Skip to main content

Table 3 Univariate and multivariate Cox regression analysis for survival

From: The pattern and treatment outcomes for rectal cancer with concurrent locoregional recurrence and distant metastases after total mesorectal excision

Related factors

Univariate

Multivariate

HR

95% CI

P value

HR

95% CI

P value

Gender

  

0.296

   

 Male

1.000

     

 Female

0.658

0.300–1.433

    

Age (years)

  

0.333

   

  < 60

1.000

     

  ≥ 60

0.691

0.327–1.460

    

Primary tumor location: distance from the anal verge (cm)

  

0.856

   

  > 5

1.000

     

  ≤ 5

0.933

0.443–1.965

    

Type of local recurrence

  

0.159

   

 Anastomotic recurrence

1.000

     

 Regional lymph node metastasis

0.461

0.205–1.038

    

 Undetermined pelvic recurrence

0.565

0.182–1.751

    

Distant metastasis

  

0.023

  

0.068

 Liver/lung/localized lymph node

1.000

  

1.000

  

 3 or more organs/structures involved or peritoneal metastases

2.464

1.132–5.362

 

2.106

0.947–4.684

 

Localized abdominal recurrence

  

0.060

   

 0

1.000

     

 1–3

0.695

0.279–1.734

    

  > 3

2.011

0.696–5.806

    

Peritoneal metastases

  

0.023

  

0.513

 0–5

1.000

  

1.000

  

  > 5

2.637

1.140–6.099

 

1.380

0.526–3.623

 

Type of surgery of primary tumor

  

0.268

   

 Anterior resection

1.000

     

 Abdominoperineal resection

2.064

0.857–4.971

    

 Others

1.111

0.257–4.815

    

T stage of primary tumor

  

0.362

   

 T1-2

1.000

     

 T3

1.668

0.220–12.624

    

 T4

0.965

0.121–7.668

    

N stage of primary tumor

  

0.424

   

 N0

1.000

     

 N1

0.979

0.441–2.174

    

 N2

1.904

0.652–5.565

    

Tumor grade of primary tumor

  

0.199

   

 G1-2

1.000

     

 G3

0.551

0.222–1.368

    

Preoperative treatment of primary tumor

  

0.242

   

 Chemoradiotherapy or radiotherapy

1.000

     

 None

1.801

0.673–4.822

    

Time to recurrence

  

0.233

   

  < 24 months

1.000

     

 24–36 months

3.074

0.835–11.315

    

  > 36 months

1.779

0.599–5.290

    

No evidence of disease

  

0.014

  

0.032

 NED

1.000

  

1.000

  

 Non-NED

2.727

1.229–6.049

 

2.419

1.078–5.427